Why the study?
The benefit of prior statin use in reducing the incidence of in-hospital arrhythmia in acute coronary syndrome remains a matter of debate.
Does prior statin use reduce the incidence of in-hospital arrhythmia in patients with acute coronary syndrome?
Does prior statin use reduce the incidence of in-hospital arrhythmia in patients with acute coronary syndrome?
Prior statin use may be associated with a reduced incidence of in-hospital arrhythmias, including atrial fibrillation and ventricular tachycardia, in patients presenting with acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
May support pre-ACS statin review; leaves open confirmation by randomized trials before practice change.
BACKGROUND: The benefit of prior statin use to reduce the incidence of arrhythmia in acute coronary syndrome (ACS) is still a matter of debate. Statins have multiple pleiotropic effects, which may reduce the incidence of in-hospital arrhythmia. A systematic review and meta-analysis were performed to evaluate prior statin use and the incidence of in-hospital arrhythmia in ACS. METHODS: This systematic review was conducted as per the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). We performed a literature search through Pubmed, Proquest, EBSCOhost, and Clinicaltrial.gov. A random-effect model was used due to moderate heterogeneity. Quality assessment was performed using Newcastle Ottawa Scale. Sensitivity analysis was performed by using leave one or two out method. PROSPERO registration number: CRD42022336402. RESULTS: = 8%, P-heterogeneity = 0.35). CONCLUSIONS: Based on aggregate patient data, prior statin use may reduce the incidence of in-hospital arrhythmia during ACS, particularly atrial fibrillation or atrial flutter and ventricular tachycardia or ventricular fibrillation.
No takes yet. Share an insight, caveat, or question.
Wibawa et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: